Interferon-β: treatment option against COVID-19

Interferon-β: treatment option against COVID-19

Faiz Ul haq, Muhammad Usman Khan, Ayesha Muazzam, Hajrah Farooq, Javeria Iqbal, Muhammad Imran, Rabia Bashir, Sania Ahmad, Sara Arif

In December 2019, an increasing number of cases of novel coronavirus (2019-nCoV) that were linked to seafood wholesale market have identified in Wuhan, China. Taxonomist declared 2019-nCoV as severe acute respiratory syndrome coronavirus- 2 (SARS-CoV-2) and the disease termed as COVID-19. Importantly, there is no approved drugs or vaccine against SARS-CoV-2. Current review is related to address treatment option for COVID-19. Interferon-β have shown significant activity against previous outbreak of SARS-CoV and MERS-CoV. Faced with an ongoing pandemic of SARS-CoV-2 and lack of effective treatment options, identifying compounds with antiviral activity has become a high priority. Efficacy of these treatments is still unclear. Therefore, final analysis is important to develop better treatment strategies for ongoing pandemic.

2020

coronavirus, covid-19, SARS-CoV-2, antiviral agents, interferon-β

10.4081/gc.2020.9093

Geriatric Care

PAGEPress Publications

Geriatrics